- Poster presentation
- Open Access
The endothelial glycocalyx degenerates with increasing sepsis severity
Critical Care volume 15, Article number: P22 (2011)
The endothelial glycocalyx is a recently discovered structure at the luminal side of blood vessels consisting of proteoglycans and glycosaminoglycans, which play an important role in vascular barrier function and cell adhesion. Due to its vulnerability, the endothelial glycocalyx may easily be altered by hypoxia , TNFα , oxidized lipoproteins  and other nonphysiological conditions. We raised the question of whether the glycocalyx may be shed from the endothelium in dependence of severity of sepsis.
This clinical prospective study - approved by the local ethics committee - was performed to assess plasma levels of the glycocalyx components (hyaluronane, syndecan, heparan sulfate) by ELISA technique and polymorphonuclear leukocyte (PMN) function by flow cytometry in eight healthy volunteers (HV) and 37 patients who were prospectively enrolled within 24 hours of onset of signs of infection, if they met the criteria for sepsis (n = 10), severe sepsis (n = 9) and septic shock (n = 18) as defined by the members of the ACCP/SCCM Consensus Conference Committee (Table 1). Blood was drawn within 24 hours after onset of sepsis. Informed consent was obtained from all patients or their legal representatives, respectively.
Plasma levels of the glycocalyx components were significantly higher in septic patients than in healthy volunteers and even more pronounced in patients with severe sepsis and septic shock (all P < 0.05; Figure 1). Hyaluronan and syndecan plasma levels correlated positively with the APACHE II, SOFA and MOD scores (Figure 1 and Table 2). Hyaluronan displayed a positive correlation with the C-reactive protein, procalcitonin and IL-6 in plasma (Table 3). The PMN dysfunction - characterized by an increase in cytotoxic capability and a decrease in microbicidity - showed a parallel course to the heparan sulfate plasma levels.
Elevated plasma levels of hyaluronan, syndecan and heparan sulfate are suggestive of a glycocalyx shedding from endothelium with increasing sepsis severity. This process might contribute to the vascular dysfunction and development of edema in septic patients.
Rehm M, Bruegger D, Christ F, et al.: Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007, 116: 1896-1906. 10.1161/CIRCULATIONAHA.106.684852
Henry CB, Duling BR: TNFα increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol 2000, 279: H2815-H2823.
Vink H, Constantinescu AA, Spaan JA: Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation 2000, 101: 1500-1502.
About this article
Cite this article
Köhler, M., Kaufmann, I., Briegel, J. et al. The endothelial glycocalyx degenerates with increasing sepsis severity. Crit Care 15 (Suppl 3), P22 (2011). https://doi.org/10.1186/cc10391
- Septic Shock
- Heparan Sulfate
- Septic Patient